] i in ARC neurons was blocked by the AMPK inhibitor compound C (20 µmol/L), and enhanced by the GSK3β inhibitor LiCl (10 mmol/L). Moreover, lowering glucose level induced the phosphorylation of AMPK and GSK3β, which was inhibited by compound C (20 µmol/L). Conclusion: Lowering glucose level enhances the activity of P/Q type Ca 2+ channels and elevates [Ca 2+ ] i level in hypothalamic arcuate nucleus neurons via inhibition of GSK3β.
Introduction
The prevalence of obesity, an important risk factor for the development of type 2 diabetes, is increasing dramatically, and the number of obese individuals worldwide is now projected to reach as many as 1.1 billion by 2030 [1, 2] . Currently, however, the behavioral and physiological cues leading to imbalanced food intake and energy expenditure remains poorly defined.
Hypothalamic neuropeptide Y and agouti-related peptide (NPY/AgRP) neurons are critical in food intake and energy homeostasis [3] [4] [5] , especially in glucose homeostasis [6] and it has been reported that a decrease in extracellular glucose concentration increases the intracellular calcium signals in neurons isolated from arcuate nucleus (ARC) of rat, and 94% of them are immunoreactive for NPY [7] . Thus ARC-NPY neurons are closely related to obesity and diabetes [5, 8] . Glucose sensing in hypothalamic NPY/AgRP neurons needs the activation of AMP-activated protein kinase (AMPK) [9] [10] [11] [12] . AMPK is activated when the AMP-to-ATP ratio increases [9, 13] . The knockout of mice AMPKα2 induces the responses to changes in extracellular glucose levels in NPY neurons [13] . The change in action potential can be stimulated by AMPK activator AICAR and blocked by AMPK inhibitor compound C [14] [15] [16] . Decreased glucose activates AMPK and elevates [Ca 2+ ] i in NPY neurons [15] . The similar process is also observed by administration of many metabolic hormones, such as leptin, insulin and www.chinaphar.com Chen Y et al Acta Pharmacologica Sinica npg ghrelin to ARC NPY neurons [17] . Our previous study showed that leptin, which inhibits AMPK in central nervous system [12] , can decrease the peak amplitude of high voltage-activated calcium currents in the isolated neurons from ARC [18] . Therefore, the activation of AMPK is crucial in the change in excitability of ARC-NPY neurons. However, the possible role of AMPK activation in the regulation of ion channels in NPY neurons remains to be elucidated.
Calcium ions are probably the most widely used intracellular messengers, and voltage-gated calcium channels (VGCCs) play key role in regulating intracellular calcium concentration during depolarization [19] . Being a state of energy deficit, decrease in extracellular glucose levels induces membrane depolarization and increases the firing rate of action potential in NPY neurons [13] . But the underlying mechanism of glucose decrease induced intracellular elevation is still uncertain [7] . Furthermore, the inhibition of AMPK-mediated GSK3β inhibition has been found both in hepatic and cortical neuronal cells [20] [21] [22] . In our previous study, it was found that GSK3β phosphorylated P/Q-type calcium channel in hippocampal neurons [23] . It is possible that AMPK may be involved in the depolarization due to calcium influx through VGCCs. However, little is known about the subtype of VGCC which contributes to the calcium elevation in ARC-NPY neurons.
In the present study, using calcium imaging to determine the source of glucose decrease induced [Ca 2+ ] i elevation and the signaling pathway, we provide evidence that AMPK activation increases glucose decrease-induced [Ca 2+ ] i response in ARC-NPY neurons via regulation of P/Q-type calcium channel by GSK3β inhibition.
Materials and methods
Chemicals DMEM/F12, Neurobasal and B27 supplement were obtained from Gibco Invitrogen Corporation (Carlsbad, CA, USA). Fura-2 AM was obtained from biotium (Hayard, CA). Other general agents were available commercially. All the drugs were prepared as stock solutions. AICAR, compound C and Fura-2 AM were dissolved in dimethylsulfoxide (DMSO). These stock solutions were diluted to the final concentrations with the HEPES-buffered solution before application. The final concentration of DMSO or ethanol did not exceed 0.1%. No detectable effects of the vehicles were found in our experiments.
Preparation of single neurons from ARC
The research was conducted in accordance with the Declaration of Helsinki and with the Guide for Care and Use of Laboratory Animals as adopted and promulgated by the United States National Institutes of Health. All experimental protocols were approved by the Review Committee for the Use of Human or Animal Subjects of Huazhong University of Science and Technology. Primary cultures of ARC neurons were prepared as previously described with some modifications [24] . Briefly, Sprague-Dawley rats, 2-4 d postnatal, were humanely killed by decapitation. After decapitation, brain slices containing the entire ARC were prepared, and entire ARC was excised from the left and right sides. The dissected tissues were removed and transferred to PBS-buffered solution containing (in mmol/L) 135 NaCl, 5 KCl, 1 CaCl 2 , 1 MgCl 2 , pH 7.3 and finely chopped. The tissues were then treated with 0.125% trypsin in PBS-balanced salt solution for 20 min at 37 °C and gently triturated using flame-polished Pasteur pipettes. Cell suspension was centrifuged for 7 min at 1000×g. Then, the cell pellets were resuspended in the Dulbecco's modified Eagle's medium (DMEM) and F-12 supplement (1:1) with 10% fetal bovine serum before plating onto glass-bottomed dishes (MatTek) coated with poly-L-lysine (20 μg/mL for 1-2 h) and kept at 37 °C in 5% CO 2 incubator. After overnight incubation in DMEM, the medium was changed to neurobasal medium (Gibco) containing 15 mmol/L glucose supplemented with 2% B27, 2 mmol/L glutamine, 10 μg/mL penicillin, and 10 μg/mL streptomycin. The ARC neurons were fed with fresh medium every 48 h. Microscopically, glial cells were not apparent in ARC neurons employing this protocol. The neurons were maintained for 7-10 d in primary culture until used for calcium imaging.
Immunocytochemical identification of single ARC neurons
The immunocytochemical identification of ARC neurons was prepared as previously reported with slight modifications [25] . ARC neurons were fixed with 4% paraformaldehyde in 0.1 mol/L PBS overnight immediately after calcium imaging. They were pretreated with H 2 O 2 in methanol for 1 h. Nonspecific binding sites were then blocked with 10% goat serum in 0.1 mol/L PBS for 1 h at room temperature. Cells were incubated overnight at 4 °C with primary antiserum to NPY diluted 1:1000 in PBS containing 1.5% normal goat serum. Cells were subsequently incubated with biotinylated goat anti-rabbit IgG secondary antibody for 1 h at room temperature. The secondary antibody was then rinsed, and the sections were labeled with avidin-peroxidase complex reagent (ABC kit; Vector) for 1 h. The sections were developed with 3,3-diaminobenzidine (DAB). In control sections, the primary antibodies were replaced by the corresponding nonspecific IgG and processed in parallel. ] i changes were measured by a Ratio Vision digital fluorescence microscopy system (TILL Photonics GmbH, Germany). Fura-2 AM loaded cells were illuminated at 340 nm for 150 ms and 380 nm for 50 ms at 1 s intervals using a TILL Polychrome monochromator. Fura-2 fluorescence emission was imaged at 510 nm by an intensified cooled charge coupled device (TILL Photonics GmbH). F 340 /F 380 fluorescence ratios were generated by TILL VISION 4.0 software. The contours of a single neuron were used to define a region of interest (ROI) from which the mean fluorescence was measured. Paired F 340 /F 380 fluorescence ratio images of ROI were acquired every second. The intracellular free calcium concentration was presented as the ratio of the fluorescence signals obtained (340/380 nm). All experiments were repeated three times using different batches of cells.
Ca

Western blot analysis
The protocol of western blot refers to our previous articles. Cultures were treated as described in results; 30 mg of intracellular proteins were loaded in each lane for comparison with β-actin as loading control. Following SDS-PAGE, the proteins were transferred to polyvinylidene difluoride membrane. Immunodetection was performed overnight at 4 °C using rabbit polyclonal antibodies against each protein below: antiphospho-AMPKα (Thr172; 1:1000; CST, USA), anti-AMPKα (1: 1000; CST, USA). Monoclonal antibody (mAb) against total GSK-3β (1:1000 for Western blotting, Abcam, Cambridge, UK), polyclonal antibody (pAb) against phosphorylated GSK-3β at Ser9 (1:1000 for western blotting, Abcam, Cambridge, UK), anti-β-actin (1:5000; Santa Cruz, CA, USA). Membranes were then incubated with a horseradish peroxidase-conjugated secondary antibody (anti-rabbit 1:10 000; Jackson Immunoresearch) for 1 h at room temperature before signals were visualized using the SuperSignal west Pico ECL kit (Thermo Scientific, Rockford, IL, USA). Quantification was performed using Scion Image software (Fredrick, MD, USA). Results are presented as percentage of control after normalization to β-actin. The effect of experimental manipulations on AMPK phosphorylation was determined using one-way ANOVA.
Whole-cell patch-clamp recording
The procedures for whole-cell patch-clamp recording were according to previous research [26, 27] and as what described in our previous reports with minor modification [18, 28] . After establishing a whole-cell configuration, the adjustment of capacitance compensation and series resistance compensation were done before recording. The current signals were acquired at a sampling rate of 10 kHz and filtered at 3 kHz. whole-cell patch-clamp recordings were carried out using an EPC-10 amplifier (HEKA, Lambrecht, Germany) driven by Pulse/PulseFit software (HEKA, Southboro, Germany). Drug actions were measured only after steady-state conditions were reached, which were judged by the amplitudes and time courses of currents remaining constant. All the recordings were made at room temperature (20-22 °C) . All experiments were repeated three times using different batches of cells and at least three to four dishes with cells were used for recording in different batches of cells.
Statistical analysis
The amplitude of [Ca 2+ ] i transient represents the difference between baseline concentration and the transient peak response to the stimulation. This amplitude is expressed in the percentage (%) change of F 340 /F 380 and calculated by (R peak -R basal ) divided by R basal . Statistical significance between the multiple groups was determined using one-way ANOVA followed by post hoc comparisons (SPSS 11.5 software). Data are presented as mean±SEM. Differences at the P<0.05 level were considered statistically significant.
Results
Morphological features of ARC-NPY neurons
The cells were fixed for immunocytochemical identification of NPY neurons immediately after the calcium imaging records were finished with the method as described before [18, 29] . The NPY neurons are typically small and medium neurons with triangular or spindle-shaped perikaryons. Most of them have one to three slender, poorly ramified primary dendrites (Figure 1 ), which are consistent with the observations by van den [25] (2004) and our previous work [18, 29] (2008 and 2010).
Decreased extracellular glucose elevates [Ca 2+ ] i in ARC-NPY neurons
We first tested the effect of glucose decrease on intracellular Ca 2+ mobilization in ARC-NPY neurons. Primary cultured rat ARC NPY neurons were loaded with Fura-2 AM and monitored by fluorescence imaging with excitation wavelengths of 340 and 380 nm. we found that a decrease in glucose concentration from 10 mmol/L to 1 mmol/L induced a transient increase in intracellular Ca 2+ ( Figure 2A ) in 25% control neurons (37 of 146, Figure 2E ). In contrast, this elevation can not be observed in cultured cortical and hippocampal neurons ( Figure 2B and Figure 2C ). Thus, our following research focused on these positive-reaction ARC-NPY neurons. Figure 3B ), indicating an extracellular calcium-dependent mechanism.
To determine whether receptor-operated calcium channels (ROCC) are involved in decreased glucose concentrationinduced [Ca 2+ ] i response, we used NMDA receptor blocker MK801, D-APV and specific AMPA receptor blocker CNQX. After pretreated with one of the three blockers for 5 min, the ARC-NPY neurons were perfused with HEPES-buffered low glucose (1 mmol/L) in the presence of blockers. The basal level of [Ca 2+ ] i was elevated by 32.8%±3.6% in MK801 (10 μmol/L)-treated group (n=16, Figure 3C ), 39.2%±7.6% in D-APV (20 μmol/L)-treated group (n=9, Figure 3D ) and 28.7%±1.6% in CNQX (50 μmol/L)-treated group (n=29, Figure  3E ), respectively. There are no significant difference between control group and those groups ( Figure 3F ), suggesting that neither NMDA receptor nor AMPA receptor mediates the reduction of glucose concentration-induced [Ca 2+ ] i increase in ARC-NPY neurons.
The amplitude of HVA current, not LVA current, is augmented by glucose decrease Next we want to know whether action potential is involved in glucose decrease induced calcium influx. We firstly used voltage-gated sodium channel blocker tetrodotoxin (TTX) to identify this possibility. we found that glucose decrease induced [Ca 2+ ] i increase could not be observed when TTX (5 μmol/L) existed ( Figure 4A , 4B, and 4C). Thus, this glucose decrease induced [Ca 2+ ] i increase is probably related to the change of membrane potential. Therefore, we used patch clamp to identify the effect of glucose decrease on VGCC currents.
In the whole-cell patch-clamp recording for I HVA , the cells were stepped from the holding potential of -80 mV to -40 mV (50 ms), and then depolarized to +10 mV (200 ms) after briefly hyperpolarized to -45 mV for 10 ms. I HVA was activated by the second depolarization. The protocol was applied about every 40 s. Extracellular glucose decrease from 10 mmol/L to 1 mmol/L significantly augmented I HVA amplitude in NPY In the whole-cell patch-clamp recording for I LVA , the cell membrane voltage was held at -90 mV, and whole cell currents were recorded in response to step pulses at different test potentials. I LVA were elicited by voltage steps to -20 mV from a holding potential of -90 mV, and the amplitude of the peak current was measured for analysis. Extracellular glucose decrease from 10 mmol/L to 1 mmol/L did not significantly alter I LVA amplitude in NPY neurons ( Figure 4F , 4G, and 4H).
Blockade of P/Q-type calcium channel, not T-type, L-type, and N-type calcium channel, inhibits the decreased glucose-induced [Ca 2+ ] i response in ARC-NPY neurons To identify which kind of VGCC is involved in the glucose decrease-induced [Ca 2+ ] i elevation, specific calcium channel blockers were used as described before [27, [30] [31] [32] . Mibefradil (5 μmol/L), the blocker of T-type calcium channel, could not block the the glucose decrease-induced [Ca 2+ ] i elevation. The amplitude of [Ca 2+ ] i elevation was 39.0%±5.8% (n=8, Figure  5B ). Neither L-type calcium channel blocker nifedipine (10 μmol/L) nor N-type calcium channel blocker ω-conotoxin GVIA (300 nmol/L) inhibited the glucose decrease-induced [Ca 2+ ] i elevation. The basal level was increased by 31.8%±6.3% (n=6) and 26.1%±2.9% (n=17), respectively ( Figure 5C and 5D) . On the contrast, P/Q-type calcium channel blocker ω-agatoxin TK (100 nmol/L) completely depressed [Ca 2+ ] i elevation in ARC-NPY neurons (n=8, Figure 5E , P<0.01 vs control). There is no significant difference between control group and those groups except ω-agatoxin TK group ( Figure 5F ). Thus, glucose decrease-induced [Ca 2+ ] i influx is via P/Q-type calcium channel.
AMPK activation contributes to [Ca 2+ ] i increase induced by decreased glucose in ARC-NPY neurons
To identify whether AMPK is activated in glucose decrease, the time dependent AMPK activation is tested 1, 2, and 5 min after glucose reduction in NPY neurons. By western blot analysis, we found that decreasing glucose concentration from 10 to 1 mmol/L remarkably increased AMPKα-subunit phosphorylation in primary ARC neurons to 142%±5.9% (n=3, P<0.05) and 118%±1.2% (n=3, P<0.05 vs 10 mmol/L glucose) by 2 min and 5 min glucose decrease; and this increased phosphorylation could be abolished by pretreatment with Compound C (20 μmol/L), the AMPK inhibitor (n=3, P<0.05 vs 1 mmol/L glucose). However there was no significant difference between each group by 1 min treatment ( Figure 6A, 6B,  n=3) . It suggests that AMPK is activated 2 min and 5 min after glucose decrease.
Using calcium imaging, we next determined whether AMPK activation mediated the [Ca 2+ ] i elevation induced by decreased glucose in ARC-NPY neurons. As shown in Figure 6D and The inhibition effect of AMPK activation on GSK3β mimics the glucose decrease induced [Ca 2+ ] i elevation in primary cultured ARC-NPY neurons AMPK activation inhibits the activity of GSK3β in the liver and epithelial cells [20, 33, 34] , next we want to reveal whether this inhibition also exists in the hypothalamus. After cultured ARC-NPY neurons were treated with AICAR (200 μmol/L), an AMPK activator for 2 min, the phosphorylation of GSK3β was significantly increased (n=3, P<0.01 vs control); and this effect could be blocked by compound C (20 μmol/L) (n=3, P<0.01 vs AICAR group, Figure 7A and 7B). Our previous study has shown that GSK3β can regulate P/Q-type calcium channel via phosphorylation [23] . Therefore, we investigated whether decreased glucose concentration from 10 to 1 mmol/L remarkably increased GSK3β phosphorylation in primary ARC neurons by 1, 2, and 5 min treatment ( Figure 7C ). Similar to the result of AMPK phosphorylation, p-GSK3β was significantly increased by 77.4%±8.9% and 67.4%±2.5% by 2 min and 5 min after glucose decrease (n=3, P<0.05 vs 10 mmol/L glucose, Figure 7D ). There was no significant difference after 1 min treatment ( Figure 7D, n=3) . Additionally, inhibition of AMPK by compound C (20 μmol/L) could depress the increased p-GSK3β induced by glucose decrease (n=3, P<0.05 vs 1 Figure 7C and 7D). Thus we can find that GSK3β is inhibited 2 min and 5 min after glucose decrease; furthermore AMPK activation is required in the inhibition of GSK3β in this process. Considering that glucose decrease induced GSK3β inhibition, we therefore investigated whether AMPK activation contributed to GSK3β inhibition in glucose decrease-induced [Ca 2+ ] i change in ARC-NPY neurons. Lithium chloride can often be used to inhibit GSK 3β activity. In our experiment lithium (10 mmol/L) obviously increased [Ca 2+ ] i from 28.7%±1.6% (n=37, Figure 7E ) to 45.3%±14.6% (n=8, Figure 7F ). It suggests that AMPK activation contributes to GSK3β inhibition in glucose decrease-induced [Ca 2+ ] i change in ARC-NPY neurons ( Figure 7G ).
Discussion
In this study, it was demonstrated that P/Q-type calcium channel contributed to glucose decrease-induced [Ca 2+ ] i elevation via an AMPK-dependent manner, and GSK3β inhibition facilitated P/Q-type calcium channel activity. Decreased glucose concentration activated cellular energy sensor AMPK, and, in turn, phosphorylated GSK3β. Thus, phosphorylated GSK3β alleviated its inhibition on P/Q-type calcium channel and induced [Ca ] i elevation by decreasing concentrations of glucose. In contrast, neither hippocampal nor cortical neurons responded to decreased glucose over the same concentration range and induce the increase of [Ca 2+ ] i , which shows that the effect is specific in glucose sensing neurons in hypothalamus. This is concordant with the previous report that the activity of cortical neurons becomes silent when glucose is reduced from 5 mmol/L to 0 mmol/L [35] . In addition, this [Ca 2+ ] i elevation can be abolished via a Ca 2+ free extracellular fluid perfusion. This result suggests an extracellular calcium-dependent mechanism. Thus, concerning depolarization of ARC-NPY induced by glucose decrease [16, 36] , we wondered that whether action potential is associated with this [Ca 2+ ] i elevation. The administration of TTX verified the [Ca 2+ ] i elevation is related to the change of membrane potential. Therefore, we hypothesized VGCC as a source of glucose decrease-induced [Ca 2+ ] i elevation in NPY neuron. Using whole cell patch clamp, we found that when extracellular glucose concentration decreases from 10 mmol/L to 1 mmol/L, the amplitude of I HVA, but not I LVA , was significantly augmented in ARC NPY neurons. Some previous studies demonstrate that N-type calcium channel may be involved in the regulation of hormones on rat arcuate nucleus [37, 38] ; our present results showed that P/Q-type calcium channel con- ] i elevation will influence the downstream signaling molecules, such as CaMKK2, and finally regulate food intake [39] . It has been reported that AMPK activation can simulate the effect of glucose decrease in NPY neurons [14] . Since extracellular glucose concentrations decrease, the rate of glucose uptake [40] and metabolism [41] will fall. Then, the resultant increase in the AMP to ATP ratio is expected to activate AMPK [42] , which will in turn promote ATP synthesis and restore the AMP to ATP ratio. AMPK is activated when cells undergo an energy stress and it has been hypothesized that glycogen synthesis would be shut down by energy consuming processes through activation of AMPK in skeletal muscle [43] . The later study provides evidence for GSK-3β inhibition by AMPK activator, AICAR [44] . In addition, AMPK can inactivate downstream GSK3β through Ser 9 phosphorylation both in direct [20] and indirect [45] ways. p-AMPK is elevated and GSK3β is also inhibited via phosphorylation in ARC-NPY neurons facing glucose decrease. Although previous researches have reported the inhibitory effect of p-AMPK on GSK3β, it is intriguing to observe this hypothalamic regulation of glucose decrease on [Ca 2+ ] i of ARC-NPY neurons through this signaling pathway, and reveal the potential involvement of the inhibition effect of p-AMPK on GSK3 in food intake and energy homeostasis.
Lithium is used to inhibit GSK-3β activity [46] . And calcium imaging showed that lithium could largely enhance [Ca 2+ ] i elevation in ARC-NPY neurons, which evidenced a GSK3β-dependent mechanism. As illustrated above, this glucose decrease-dependent [Ca 2+ ] i elevation is probably related to P/ Q-type calcium channels. While in recent report, GSK3β can phosphorylate the intracellular loop-connecting domains of P/ Q-type calcium channels, which leads to a decrease of [Ca 2+ ] i elevation through the P/Q-type voltage-dependent calcium channel [23] . Therefore, it is reasonable to attribute [Ca 2+ ] i elevation to de-inactivation of P/Q-type calcium channel (Figure 8 The difference of p-AMPKα between each group was not significant when neurons were treated for 1 min (n=3). There was significant difference between 1 mmol/L glucose group and other group after 2 min treatment, while the difference between control group and compound C group was not significant. Immunoblots of p-AMPKα were measured using image J. ] i reflects the excitation of neuron. Glucose-inhibited neurons are always excited when glucose concentration decrease to a certain level. In previous report, the in vivo glucose concentration to which hypothalamic glucoseinhibited neurons are exposed is still controversial. In early studies about hypothalamic glucose-sensing, the extracellular glucose levels in the brain were measured at different plasma glucose concentrations. The brain glucose level varies from 1 to 2.5 mmol/L when the plasma glucose is altered from 5 to 8 mmol/L in normoglycemia [47] . when plasma glucose level is at 15-17 mmol/L in hyperglycemia, brain concentrations are at 4.5 mmol/L [48] . while all those researches focused on glucose-excited neuron to illustrate a mechanism of glucoseincrease excitation. Therefore, in most hypothalamic neuron culture protocol, neurons were cultured in a relatively high glucose surroundings depending on different medium used in experiments [15, 49] . Moreover, it has been argued that the hypo- [50] , so that hypothalamus might be exposed to the levels closer to those measured in the plasma. Therefore, to avoid the disturbance of a dramatic change of extracellular fluid on neurons which are to be tested, we used a relatively acceptable glucose level of 10 mmol/L for incubation and the low limit of perfusion fluid is 1.0 mmol/L in the range as reported [48, 51, 52] . To maintain the glucose concentration in a certain scale, the regulation of daily change of glucose concentration is important. Therefore, the regulation of ARC-NPY excitability is crucial, which underlies the mechanism of food intake regulation and energy homeostasis [25, 53] . As a feature of central neurons, electrophysiology activity is an intrinsic character of hypothalamic ARC-NPY neurons. Therefore, their excitation is undoubtedly regulated by ion channel especially calcium channels. And calcium is important for ARC-NPY neurons' activity as a second messenger [37] . Thus, we focused on calcium channels to illustrate their role in hypothalamic metabolism homeostasis. In our results, GSK3β and P/Q-type calcium channel integrate energy sensing signaling to hypothalamic electrophysiology activity. Although this P/Q-type calcium channel-based mechanism contributes to the glucosedecrease dependent [Ca 2+ ] i increase, we still can't exclude the possibility of calcium-induced calcium release. Accordingly, it will be the next step for us to identify the intracellular mechanism.
Conclusion
In summary, we showed that P/Q-type calcium channel contributes to glucose-decrease induced [Ca 2+ ] i increase in hypothalamic ARC-NPY neurons. This process is dependent on the activation of AMPK, and its inhibitory effect on GSK3β contributes to the attenuation of the blockade on P/Q-type calcium channels. These results directly link VGCCs to glucose sensing. Our work opens up the possibility of using modulators of ion channels to control energy homeostasis and the conditions of aberrant food intake such as obesity and diabetes. Figure 8 . The summary diagrams of current studies and proposed model. Schematic of glucose decrease induced hypothalamic ARC-NPY neurons intracellular calcium elevation. The activation of AMPK inhibited GSK3β, and subsequently alleviated the inhibition of GSK3β on P/Q type calcium channel and lastly increased calcium influx through P/Q type calcium channel .
